Shingles immunisation programme from September 2016

The fourth year of the shingles (herpes zoster) immunisation programme aims to vaccinate patients aged 70-73 years and 78-79 years.

By the end of March 2016, just under half of all eligible 70- and 78-year-olds had been vaccinated against shingles.  | SCIENCE PHOTO LIBRARY
By the end of March 2016, just under half of all eligible 70- and 78-year-olds had been vaccinated against shingles. | SCIENCE PHOTO LIBRARY

From 1st September 2016, GPs should offer shingles vaccine (Zostavax) to patients aged 70 or 78 years on the 1st September 2016.

Further information
View Zostavax drug record
Letter from PHE

Patients who have been eligible in previous years but remain unvaccinated may also be offered the vaccine. These are patients aged 71–73 years or 79 years on 1st September 2016.

Anyone who reaches their 80th birthday is no longer eligible for immunisation owing to the vaccine's declining efficacy with increasing age.

During the 2015/16 programme, just under half of eligible 70- and 78-year-olds had been vaccinated by the end of March 2016, PHE and NHS England report.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases